May 09, 2019
Catalent Achieves Global ISO Accreditation, Becomes One of the First Contract Development and Manufacturing Organizations to Receive Award
Apr 29, 2019
Catalent Invests $40 Million to Increase Patient-Centric Dose Form Manufacturing Capabilities at Winchester, Kentucky
Apr 04, 2019
Catalent Expands OptiMelt® Hot Melt Extrusion Capabilities at Somerset Drug Development Center of Excellence
Apr 01, 2019
Triphase Accelerator Initiates Phase 1 Clinical Trial of TRPH-222 in B-cell Lymphoma
Mar 21, 2019
Catalent Signs CEO Action for Diversity and Inclusion Pledge
Mar 19, 2019
Advances in Biologics Development to be Discussed at Symposium Hosted by the Catalent Applied Drug Delivery Institute at the UCSF Mission Bay Campus
Mar 12, 2019
Techniques for Achieving High Dose Accuracy to be Presented by Catalent Biologics Experts at ISPE Aseptic Conference
Mar 07, 2019
Catalent Invests Over $27 Million to Commercialize Zydis® Ultra, a Next Generation Oral Disintegrating Tablet
Feb 21, 2019
Catalent Appoints Kay Schmidt to Executive Leadership Team to Lead New Technical Operations Organization
Feb 18, 2019
Catalent Receives P&G External Business Partner of the Year Award
Jan 29, 2019
Smart Drug Development and Design to be Discussed at Symposium Hosted by Catalent Applied Drug Delivery Institute and Boehringer Ingelheim
Jan 24, 2019
Debate on Patient-Focused Biologic Design to be Led by Catalent at Drug Delivery Partnerships
Jan 17, 2019
Assay Automation to be Presented by Catalent Biologics Expert at WCBP Symposium
Dec 03, 2018
Catalent Invests $14 Million to Expand Biologics Packaging Capabilities Following Twentieth Commercial Drug Approval at Bloomington, Indiana Site
Dec 03, 2018
Biohaven Delivers Positive Phase 3 Results with Rimegepant Zydis® Orally Dissolving Tablet (ODT): Rapid and Lasting Benefit for the Acute Treatment of Migraine
Nov 26, 2018
Catalent Expands Clinical Packaging Capabilities in Shanghai, China
Nov 15, 2018
Catalent Expert to Discuss Ways to Mitigate the Effects of Brexit on Clinical Trial Supply at PCT Europe Conference
Nov 06, 2018
Continuous Bioprocessing and Cell Line Development to be Presented by Catalent at The Waterside Conference(TM)
Oct 17, 2018
Patient-Focused Drug Delivery to be Presented by Catalent at PODD
Oct 10, 2018
Catalent Clinical Supply Experts to Present at Two Upcoming Industry Conferences in Europe and Asia